Filing Details
Lipocine Inc. (NASDAQ:LPCN) filed a Form 8-K with the Securities and Exchange Commission on October 07, 2026, disclosing a material event.
8k filedNASDAQ:LPCN
Lipocine Inc. (LPCN) Reports Material Event to SEC
Lipocine Inc. (NASDAQ:LPCN) filed a Form 8-K with the Securities and Exchange Commission on October 07, 2026, disclosing a material event.
At publication ·
What changed
Lipocine Inc. (NASDAQ:LPCN) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Lipocine Inc. filed a Form 8-K on October 7, 2026, disclosing a material event, though the specific nature was not detailed in this announcement.
- The company's stock trades at $2.20 with a market capitalization of $17.1 million.
- Form 8-K filings report events such as leadership changes, material agreements, acquisitions, or asset sales that shareholders should know about between regular reports.
Market Context
Lipocine Inc.'s stock currently trades at $2.20 with a market capitalization of $17.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Lipocine Inc.'s stock.
All SEC filings for Lipocine Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View LPCN Stock Page
Frequently Asked Questions
Where can I read LPCN's SEC filings?
Browse all filings on our LPCN SEC filings page.
What types of SEC filings does Lipocine Inc. file?
Public companies like Lipocine Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.